Board reviews measures for Trader Welfare and Export Promotion (See 'Corp Brief') DRI seizes 9.40 kg gold worth Rs. 15 crore at Mumbai airport (See 'Corp Brief') NLMC concludes 3-City Investor Outreach Programme for RINL Land E-Auction (See 'Corp Brief') MEE-TR 2026 to introduce 'Solid Waste Management' as separate Evaluation Criterion of Tiger Reserves (See 'Corp Brief') Nadda inaugurates Arogya Manthan 2026, marking 8 years of AB PM-JAY (See 'Corp Brief') Union Minister inaugurates Seva First Innovation Challenge at IISc Bengaluru (See 'Corp Brief') Bharat CPSEs' Consultative Conclave inaugurated at Gati Shakti Vishwavidyalaya (See 'Corp Brief') SAIL's 54th AGM highlights strong value added steel growth (See 'Corp Brief') TDB-DST signs pact with GalaxEye to develop next-generation multisensor satellite technology (See 'Corp Brief') Nadda to inaugurate Arogya Manthan 2026 at Vigyan Bhawan (See 'Corp Brief') IPR - Civil remedy u/s 55 of Copyright Act can be pursued through arbitration as agreed alternative dispute resolution mechanism: HC (See 'Legal Desk') Railways approves Rs 166 Crore for construction of Road Over Bridge in Vadodara (See 'Corp Brief') ICAR-CMFRI advises Consumers Not to Avoid Tuna (See 'Corp Brief') IPR - Scheduled Commercial Bank which is registered proprietor of well-known formative trademarks can maintain commercial suit for infringement and passing off against unauthorised third parties who use those marks on social media to hold themselves out as agents capable of procuring loan settlements: HC (See 'Legal Desk') Indo-Africa Roundtable on WASH held as part of India International WASH Conference (See 'Corp Brief') Naik holds meeting with European Parliament's Committee on Industry (See 'Corp Brief') A&C - If a company is employed as conduit for shielding assets from creditors, Court may look beyond corporate structure, for piercing veil: HC (See 'Legal Desk') CCI approves acquisition of Onesto Labs by L'Oréal India (See 'Corp Brief') CCI approves acquisition of equity share of IIFL Capital by FIH Mauritius (See 'Corp Brief') IPR - If party adopts mark that is deceptively similar to registered mark for identical goods, with full knowledge of prior statutory and common law rights, such adoption constitutes infringement: HC (See 'Legal Desk') National Rainfed Area Authority organizes High Level meeting for Watershed Development (See 'Corp Brief') Railways connects Remote Area of South Chhattisgarh (See 'Corp Brief') IPR - Requiring plaintiff to sue at place of its subordinate office because cause of action has arisen there would amount to re-writing Sec 134 of Trade Marks Act: HC (See 'Legal Desk') Rs 46 Crore released for Rehabilitation of Persons Engaged in Begging (See 'Corp Brief') FEMA - The fact that penalty falls within statutory maximum does not, by itself, validate quantum imposed: HC (See 'Legal Desk') Experts deliberate on WTO Fisheries Subsidies Pact & Implementation Challenges (See 'Corp Brief') Companies Act - Admission of winding-up petition, appointment of provisional liquidator or liquidator, or possession of assets by liquidator does not, by itself, establish irreversibility thereof: HC (See 'Legal Desk') 7th High-Level meeting of OPEC-India Energy Dialogue held in Delhi (See 'Corp Brief') Competition - Formulation of technical specifications & procurement requirements falls primarily within domain of procuring entities, which are at liberty to set terms suited to their needs - no case of contravention of Sections 3 or 4 is made out: CCI (See 'Legal Desk') NHAI signs MoU with SSNNL to simplify Approval Framework for NH (See 'Corp Brief') PMLA - Provisional attachment order unsustainable when there is no apprehension or evidence that subject property is likely to be transferred, concealed or in some way disposed off so as to frustrate confiscation proceedings: SAFEMA Tribunal (See 'Legal Desk') Union Minister inaugurates WWF Global Conservation Conference at Jaipur (See 'Corp Brief') Ministry of MSME gears Up for Special Campaign 6.0 on Swachhata (See 'Corp Brief') SECI celebrates 15th Foundation Day with Stakeholders' Meet (See 'Corp Brief') A&C - Agent cannot claim cross-contractual lien over principal's property for dues arising under separate agreements in absence of express contractual provision permitting such retention: HC (See 'Legal Desk') Coal India advances Technology-led Diversification Across Energy & Minerals (See 'Corp Brief') Digital India RISC-V Grand Challenge under C2S Programme awarded to 3 teams (See 'Corp Brief') IBC - Arrangement of funds to enable corporate debtor to clear its liabilities, coupled with transfer of funds from cooperative bank loan account of applicant directly to bank, is not valid loan disbursement under IBC: NCLT (See 'Legal Desk') Vaishnaw highlights ISM 2.0, indigenous design, manufacturing, talent and India's emergence (See 'Corp Brief') SEBI - SEBI, acting as statutory market regulator, is duty-bound to issue a reasoned, speaking order when a decision carries serious civil consequences for acquirer, target company & investors: SAT (See 'Legal Desk') An unsuccessful 'success fee' litigation (See CORP EINSICHT)

Print

Glenmark's Swiss arm gets nod to market Ryaltris nasal spray in Russia

Published: Feb 22, 2021

By TIOLCORPLAWS News Service

NEW DELHI, FEB 22, 2021: GLENMARK Pharmaceuticals on Monday said its Swiss subsidiary, Glenmark Specialty, has received marketing approval from Russian health regulators for its fixed-dose combination nasal spray, Ryaltris.

Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis, like stuffy and runny nose, nasal itching, sneezing, as well as irritated eyes, in adults and children over 12 years of age.

"Glenmark has built strong capabilities in the area of respiratory medicine and is among the leading players in this therapy area across several markets globally. Russia is one of the key markets for us and we are consistently looking to expand our product portfolio," said Csaba Kantor, Senior Vice President - Russia and CIS region, Glenmark.

In Russia, allergic rhinitis affects 10-20 per cent of the population on average, with certain regions having a higher prevalence rate of 18-38 per cent.

"Glenmark has a strong established presence in Russia for over 30 years, which will enable us to lead the commercialization of this product in the country. We look forward to being able to make this innovative product available to patients in Russia as soon as possible," Mr Kantor added.

The company estimated that Ryaltris will be available to patients in Russia by the first quarter of 2021-22.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.